Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Valproic acid
Drug ID BADD_D02329
Description Valproic acid, or valproate, is an fatty acid derivative and anticonvulsant originally synthesized in 1881 by Beverly S. Burton.[A178051] It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century. In 1963, a serendipitous discovery was made by George Carraz during his investigations into the anticonvulsant effects of khelline when he found that all of his samples, dissolved in valproic acid, exerted a similar degree of anticonvulsive activity. It first received approval on February 28, 1978 from the FDA under the trade name Depakene.[L6190] Since then, it has been investigated for neuroprotective, anti-manic, and anti-migraine effects. It is currently a compound of interest in the field of oncology for its anti-proliferative effects and is the subject of many clinical trials in a variety of cancer types.
Indications and Usage For treatment and management of seizure disorders, mania, and prophylactic treatment of migraine headache. In epileptics, valproic acid is used to control absence seizures, tonic-clonic seizures (grand mal), complex partial seizures, and the seizures associated with Lennox-Gastaut syndrome.
Marketing Status Prescription; Discontinued
ATC Code N03AG01
DrugBank ID DB00313
KEGG ID D00399
MeSH ID D014635
PubChem ID 3121
TTD Drug ID D03LGY
NDC Product Code 0591-4012; 17856-0152; 63629-2454; 72189-267; 60432-621; 0121-4675; 72189-010; 43353-085; 17349-0005; 68108-0203; 71930-057; 69452-150; 62756-920; 66064-8001; 17856-0675; 11014-0054; 0121-1350; 0615-8205; 68094-701; 43353-107; 10888-8132; 11014-0050; 70518-0079; 63739-253; 70518-0730; 42291-844; 0832-0310; 23639-0003; 50383-792; 68094-193; 0121-0675; 0527-5250; 49452-8092; 63739-086; 68925-0002; 43353-279; 63629-7597; 60687-262
Synonyms Valproic Acid | 2-Propylpentanoic Acid | 2 Propylpentanoic Acid | Divalproex | Depakene | Convulsofin | Depakote | Dipropyl Acetate | Divalproex Sodium | Semisodium Valproate | Vupral | Valproic Acid, Sodium Salt (2:1) | Propylisopropylacetic Acid | Ergenyl | Magnesium Valproate | Valproate | Valproate Sodium | Sodium Valproate | Calcium Valproate | Valproate Calcium | Depakine
Chemical Information
Molecular Formula C8H16O2
CAS Registry Number 99-66-1
SMILES CCCC(CCC)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 1A2P05177Not AvailableNot Available
HepatotoxicityCytochrome P450 2A6P11509T06455Not Available
HepatotoxicityCytochrome P450 2E1P05181Not AvailableNot Available
HepatotoxicityCytochrome P450 2C9P11712T19244Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Iris coloboma06.13.03.003; 03.01.08.0020.000231%Not Available
Retinal coloboma06.13.01.007; 03.01.03.0050.000289%Not Available
Brachycephaly03.11.02.004; 15.11.02.0040.000443%Not Available
Lip injury12.01.09.016; 07.05.01.0170.000443%Not Available
Anticonvulsant drug level below therapeutic13.17.01.0230.001329%Not Available
Tracheomalacia22.04.07.011; 08.07.02.0020.000664%Not Available
Oppositional defiant disorder19.21.04.0030.002214%Not Available
Choroidal coloboma03.01.08.001; 06.13.01.0040.000173%Not Available
Hypotelorism of orbit15.11.05.005; 06.09.05.004; 03.11.05.0050.000289%Not Available
Anticonvulsant drug level decreased13.17.01.0240.001329%Not Available
Poor sucking reflex18.04.04.011; 17.02.01.0080.000443%Not Available
Sopor19.02.04.002; 17.02.04.021--Not Available
Carnitine deficiency14.08.04.0220.000664%Not Available
Head circumference abnormal13.15.01.0420.000173%Not Available
Intelligence test abnormal13.15.01.0430.001772%Not Available
Foetal malformation18.03.02.016; 03.02.01.0120.000231%Not Available
Communication disorder19.19.01.0080.002214%Not Available
Congenital cardiovascular anomaly03.07.10.001; 02.08.02.004; 24.03.03.0110.030781%Not Available
Disturbance in social behaviour19.05.01.0180.002214%Not Available
Congenital eyelid malformation06.06.04.017; 03.01.07.001; 23.07.05.0050.000289%Not Available
Foot deformity15.10.03.0050.003322%Not Available
Hand deformity15.10.03.0070.000886%Not Available
Head deformity15.10.05.0050.000886%Not Available
Neck deformity15.10.04.0090.000443%Not Available
Neutrophil count abnormal13.01.06.0180.000443%Not Available
Congenital optic nerve anomaly03.01.10.001; 17.19.02.006; 06.13.01.0050.000116%Not Available
Deformity08.01.03.0220.017677%Not Available
Nose deformity15.10.05.0060.000886%Not Available
Congenital neurological disorder17.02.10.021; 03.10.01.0060.000404%Not Available
Congenital nose malformation22.10.02.003; 03.16.04.0010.001791%Not Available
The 29th Page    First    Pre   29 30    Next   Last    Total 30 Pages